Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229–63. https://doi.org/10.3322/caac.21834.

Article  PubMed  Google Scholar 

Gliwska E, Guzek D, Przekop Z, Sobocki J, Głąbska D. Quality of Life of Cancer Patients Receiving Enteral Nutrition: A Systematic Review of Randomized Controlled Trials. Nutrients. 2021;13(12). https://doi.org/10.3390/nu13124551.

Liu B, Zhou H, Tan L, Siu KTH, Guan XY. Exploring treatment options in cancer: Tumor treatment strategies. Signal Transduct Target Ther. 2024;9(1):175. https://doi.org/10.1038/s41392-024-01856-7.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gordon MR, Canakci M, Li L, Zhuang J, Osborne B, Thayumanavan S. Field Guide to Challenges and Opportunities in Antibody-Drug Conjugates for Chemists. Bioconjug Chem. 2015;26(11):2198–215. https://doi.org/10.1021/acs.bioconjchem.5b00399.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chari RV, Miller ML, Widdison WC. Antibody-drug conjugates: an emerging concept in cancer therapy. Angew Chem Int Ed Engl. 2014;53(15):3796–827. https://doi.org/10.1002/anie.201307628.

Article  CAS  PubMed  Google Scholar 

Tian L, Ma P, Zhuang W, Xu Y, Pang L, Guo K, et al. A transferrin-targeted nanoplatform for MRI-guided visualization and potent suppression of tumors and pulmonary metastatic lesions. Nanoscale Horiz. 2025;10(10):2422–33. https://doi.org/10.1039/d5nh00325c.

Article  CAS  PubMed  Google Scholar 

Wilson EM, Eskander RN, Binder PS. Recent Therapeutic Advances in Gynecologic Oncology: A Review. Cancers (Basel). 2024;16(4). https://doi.org/10.3390/cancers16040770.

Dixit T, Aswini A, Nikam H, Vaidya A, Ravindran S. Emerging trends in synthesis, characterization, and mechanism of action of antibody-drug and antibody-nanoparticle conjugates. Discov Nano. 2025;20(1):139. https://doi.org/10.1186/s11671-025-04303-w.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ko MJ, Song D, Kim J, Kim JY, Eom J, Sung B, et al. N-terminal selective conjugation method widens the therapeutic window of antibody-drug conjugates by improving tolerability and stability. MAbs. 2021;13(1):1914885. https://doi.org/10.1080/19420862.2021.1914885.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baah S, Laws M, Rahman KM. Antibody-Drug Conjugates-A Tutorial Review. Molecules. 2021;26(10). https://doi.org/10.3390/molecules26102943.

Esapa B, Jiang J, Cheung A, Chenoweth A, Thurston DE, Karagiannis SN. Target Antigen Attributes and Their Contributions to Clinically Approved Antibody-Drug Conjugates (ADCs) in Haematopoietic and Solid Cancers. Cancers (Basel). 2023;15(6). https://doi.org/10.3390/cancers15061845.

Liu X, Cheng Y, Mu Y, Zhang Z, Tian D, Liu Y, et al. Diverse drug delivery systems for the enhancement of cancer immunotherapy: an overview. Front Immunol. 2024;15:1328145. https://doi.org/10.3389/fimmu.2024.1328145.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Parakh S, Nicolazzo J, Scott AM, Gan HK. Antibody Drug Conjugates in Glioblastoma - Is There a Future for Them? Front Oncol. 2021;11:718590. https://doi.org/10.3389/fonc.2021.718590.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Johan AN, Li Y. Development of Photoremovable Linkers as a Novel Strategy to Improve the Pharmacokinetics of Drug Conjugates and Their Potential Application in Antibody-Drug Conjugates for Cancer Therapy. Pharmaceuticals (Basel). 2022;15(6). https://doi.org/10.3390/ph15060655.

Strebhardt K, Ullrich A. Paul Ehrlich’s magic bullet concept: 100 years of progress. Nat Rev Cancer. 2008;8(6):473–80. https://doi.org/10.1038/nrc2394.

Article  CAS  PubMed  Google Scholar 

Ford CH, Newman CE, Johnson JR, Woodhouse CS, Reeder TA, Rowland GF, et al. Localisation and toxicity study of a vindesine-anti-CEA conjugate in patients with advanced cancer. Br J Cancer. 1983;47(1):35–42. https://doi.org/10.1038/bjc.1983.4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Köhler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975;256(5517):495–7. https://doi.org/10.1038/256495a0.

Article  PubMed  Google Scholar 

Beck A, Goetsch L, Dumontet C, Corvaïa N. Strategies and challenges for the next generation of antibody-drug conjugates. Nat Rev Drug Discov. 2017;16(5):315–37. https://doi.org/10.1038/nrd.2016.268.

Article  CAS  PubMed  Google Scholar 

Wang Z, Wang G, Lu H, Li H, Tang M, Tong A. Development of therapeutic antibodies for the treatment of diseases. Mol Biomed. 2022;3(1):35. https://doi.org/10.1186/s43556-022-00100-4.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yasui H, Idogawa M, Ishida T, Imai K. Therapeutic Antibodies in Hematology: Advances in Malignant and Non-Malignant Disorders. Cells. 2025;15(1). https://doi.org/10.3390/cells15010046.

Krop I, Winer EP. Trastuzumab emtansine: a novel antibody-drug conjugate for HER2-positive breast cancer. Clin Cancer Res. 2014;20(1):15–20. https://doi.org/10.1158/1078-0432.Ccr-13-0541.

Article  CAS  PubMed  Google Scholar 

Deng C, Pan B, O’Connor OA. Brentuximab vedotin. Clin Cancer Res. 2013;19(1):22–. https://doi.org/10.1158/1078-0432.Ccr-12-0290.  7.

Article  CAS  PubMed  Google Scholar 

Narayan P, Osgood CL, Singh H, Chiu HJ, Ricks TK, Chiu Yuen Chow E, et al. FDA Approval Summary: Fam-Trastuzumab Deruxtecan-Nxki for the Treatment of Unresectable or Metastatic HER2-Positive Breast Cancer. Clin Cancer Res. 2021;27(16):4478–85. https://doi.org/10.1158/1078-0432.Ccr-20-4557.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Zhao P, Zhang Y, Li W, Jeanty C, Xiang G, Dong Y. Recent advances of antibody drug conjugates for clinical applications. Acta Pharm Sin B. 2020;10(9):1589–600. https://doi.org/10.1016/j.apsb.2020.04.012.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang R, Hu B, Pan Z, Mo C, Zhao X, Liu G, et al. Antibody-Drug Conjugates (ADCs): current and future biopharmaceuticals. J Hematol Oncol. 2025;18(1):51. https://doi.org/10.1186/s13045-025-01704-3.

Article  PubMed  PubMed Central  Google Scholar 

Li SC, Luo J, Lee KL. Cancer Niche as a Garbage Disposal Machine: Implications of TCM-Mediated Balance of Body-Disease for Treatment of Cancer. Online J Complement Altern Med. 2019;1(3). https://doi.org/10.33552/ojcam.2019.01.000514.

Zhou Y, Gou LT, Guo ZH, Liu HR, Wang JM, Zhou SX, et al. Fully human HER2/cluster of differentiation 3 bispecific antibody triggers potent and specific cytotoxicity of T lymphocytes against breast cancer. Mol Med Rep. 2015;12(1):147–54. https://doi.org/10.3892/mmr.2015.3441.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rao M, Wu L, Chen H, Wu X, Wang H, Chen Y, et al. Hematological toxicity of anti-tumor antibody-drug conjugates: A retrospective pharmacovigilance study using the FDA adverse event reporting system. PLoS ONE. 2025;20(10):e0334513. https://doi.org/10.1371/journal.pone.0334513.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ou C, Li C, Zhang R, Yang Q, Zong G, Dai Y, et al. One-Pot Conversion of Free Sialoglycans to Functionalized Glycan Oxazolines and Efficient Synthesis of Homogeneous Antibody-Drug Conjugates through Site-Specific Chemoenzymatic Glycan Remodeling. Bioconjug Chem. 2021;32(8):1888–97. https://doi.org/10.1021/acs.bioconjchem.1c00314.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cao M, De Mel N, Jiao Y, Howard J, Parthemore C, Korman S, et al. Site-specific antibody-drug conjugate heterogeneity characterization and heterogeneity root cause analysis. MAbs. 2019;11(6):1064–76. https://doi.org/10.1080/19420862.2019.1624127.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yasunaga M, Manabe S, Tsuji A, Furuta M, Ogata K, Koga Y, et al. Development of Antibody-Drug Conjugates Using DDS and Molecular Imaging. Bioeng (Basel). 2017;4(3). https://doi.org/10.3390/bioengineering4030078.

Beerli RR, Hell T, Merkel AS, Grawunder U. Sortase Enzyme-Mediated Generation of Site-Specifically Conjugated Antibody Drug Conjugates with High In Vitro and In Vivo Potency. PLoS ONE. 2015;10(7):e0131177. https://doi.org/10.1371/journal.pone.0131177.

Article  CAS